JC
AVEO

JBF Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

JBF Capital’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,000
Closed -$209K – 81
2022
Q4 		$209K Buy
+14,000
New +$194K 0.05% 45

JBF Capital's AVEO Position: Q1 2023 in Review

JBF Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 14,000 shares — an estimated $209K sold.

JBF Capital first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $209K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • JBF Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • JBF Capital sold 14,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $209K.
  • JBF Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • JBF Capital's AVEO Pharmaceuticals, Inc. position peaked at $209K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on JBF Capital's 13F filing for Q1 2023, filed 12 May 2023.